Tenofovir (TDF)

DRUG6 trials

Sponsors

French National Agency for Research on AIDS and Viral Hepatitis, International Maternal Pediatric Adolescent AIDS Clinical Trials Group, Bristol-Myers Squibb, The HIV Netherlands Australia Thailand Research Collaboration, ViiV Healthcare

Conditions

HIVHIV InfectionHIV InfectionsHIV-infected Thai ChildrenPregnancy

Phase 2

Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA)

CompletedNCT00334256

French National Agency for Research on AIDS and Viral HepatitisHIV Infection, Pregnancy

Start: 2006-10-31End: 2009-12-31Updated: 2011-12-05

Strategy-confirming Study of BMS-955176 to Treat HIV-1 Infected Treatment-experienced Adults

TerminatedNCT02386098

ViiV HealthcareHIV Infections

Start: 2015-07-08End: 2017-06-07Updated: 2018-08-20

Phase 3

Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)

CompletedNCT00158457

French National Agency for Research on AIDS and Viral HepatitisHIV Infection

Start: 2004-06-30End: 2006-12-31Updated: 2007-07-03

Phase 4

Effects of Famotidine on the Pharmacokinetics of Atazanavir When Coadministered to Participants With HIV Infection

CompletedNCT01232127

Bristol-Myers SquibbHIV

Start: 2011-02-28End: 2011-06-30Updated: 2012-08-31

Unknown Phase

IMPAACT P1058A: Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults

CompletedNCT00977756

International Maternal Pediatric Adolescent AIDS Clinical Trials GroupHIV Infections

Start: 2002-08-31End: 2014-03-31Updated: 2015-08-07

TDF Long Term Study

CompletedNCT01815255

The HIV Netherlands Australia Thailand Research CollaborationHIV-infected Thai Children

Start: 2010-12-31End: 2013-08-31Updated: 2020-07-17